Trombosi molto tardiva di stent medicato coronarico in paziente affetto da trombocitemia essenziale

Caso clinico di una rara associazione

Translated title of the contribution: Very late coronary drug-eluting stent thrombosis in a patient with essential thrombocythemia: A case report of a rare association

Marco Mele, Carlo Vigna, Alessandro Villella

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Very late coronary stent thrombosis is a rare and dangerous complication associated with the use of drug-eluting stents. From registries and trials only a few predictable risk factors have been identified, though not specifically associated with this phenomenon, such as early discontinuation of dual antiplatelet therapy, diabetes mellitus, renal failure, and complex coronary lesions. Essential thrombocythemia, a rare myeloproliferative disorder characterized by increased platelet count and megakaryocytic hyperplasia in the bone marrow, is rarely associated with ischemic cardiac events or coronary stent thrombosis. We describe a case of very late coronary drug-eluting stent thrombosis in a patient affected by essential thrombocythemia and with a platelet count of 780 000/mm3, presenting with acute myocardial infarction. In our opinion, this case report enriches the poor literature about the association between two so rare conditions; moreover, to our knowledge, this is the first case described in the literature of very late coronary stent thrombosis in a patient with this prothrombotic feature.

Original languageItalian
Pages (from-to)520-522
Number of pages3
JournalGiornale Italiano di Cardiologia
Volume13
Issue number7-8
DOIs
Publication statusPublished - Jul 2012

Fingerprint

Coronary Thrombosis
Essential Thrombocythemia
Drug-Eluting Stents
Stents
Thrombosis
Platelet Count
Myeloproliferative Disorders
Hyperplasia
Renal Insufficiency
Registries
Diabetes Mellitus
Bone Marrow
Myocardial Infarction
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Trombosi molto tardiva di stent medicato coronarico in paziente affetto da trombocitemia essenziale : Caso clinico di una rara associazione. / Mele, Marco; Vigna, Carlo; Villella, Alessandro.

In: Giornale Italiano di Cardiologia, Vol. 13, No. 7-8, 07.2012, p. 520-522.

Research output: Contribution to journalArticle

@article{95b76c2b3d994ade895e4796e3a61751,
title = "Trombosi molto tardiva di stent medicato coronarico in paziente affetto da trombocitemia essenziale: Caso clinico di una rara associazione",
abstract = "Very late coronary stent thrombosis is a rare and dangerous complication associated with the use of drug-eluting stents. From registries and trials only a few predictable risk factors have been identified, though not specifically associated with this phenomenon, such as early discontinuation of dual antiplatelet therapy, diabetes mellitus, renal failure, and complex coronary lesions. Essential thrombocythemia, a rare myeloproliferative disorder characterized by increased platelet count and megakaryocytic hyperplasia in the bone marrow, is rarely associated with ischemic cardiac events or coronary stent thrombosis. We describe a case of very late coronary drug-eluting stent thrombosis in a patient affected by essential thrombocythemia and with a platelet count of 780 000/mm3, presenting with acute myocardial infarction. In our opinion, this case report enriches the poor literature about the association between two so rare conditions; moreover, to our knowledge, this is the first case described in the literature of very late coronary stent thrombosis in a patient with this prothrombotic feature.",
keywords = "Stent, Thrombocytosis, Thrombosis",
author = "Marco Mele and Carlo Vigna and Alessandro Villella",
year = "2012",
month = "7",
doi = "10.1714/1114.12248",
language = "Italian",
volume = "13",
pages = "520--522",
journal = "Giornale Italiano di Cardiologia",
issn = "1827-6806",
publisher = "CEPI s.r.l.",
number = "7-8",

}

TY - JOUR

T1 - Trombosi molto tardiva di stent medicato coronarico in paziente affetto da trombocitemia essenziale

T2 - Caso clinico di una rara associazione

AU - Mele, Marco

AU - Vigna, Carlo

AU - Villella, Alessandro

PY - 2012/7

Y1 - 2012/7

N2 - Very late coronary stent thrombosis is a rare and dangerous complication associated with the use of drug-eluting stents. From registries and trials only a few predictable risk factors have been identified, though not specifically associated with this phenomenon, such as early discontinuation of dual antiplatelet therapy, diabetes mellitus, renal failure, and complex coronary lesions. Essential thrombocythemia, a rare myeloproliferative disorder characterized by increased platelet count and megakaryocytic hyperplasia in the bone marrow, is rarely associated with ischemic cardiac events or coronary stent thrombosis. We describe a case of very late coronary drug-eluting stent thrombosis in a patient affected by essential thrombocythemia and with a platelet count of 780 000/mm3, presenting with acute myocardial infarction. In our opinion, this case report enriches the poor literature about the association between two so rare conditions; moreover, to our knowledge, this is the first case described in the literature of very late coronary stent thrombosis in a patient with this prothrombotic feature.

AB - Very late coronary stent thrombosis is a rare and dangerous complication associated with the use of drug-eluting stents. From registries and trials only a few predictable risk factors have been identified, though not specifically associated with this phenomenon, such as early discontinuation of dual antiplatelet therapy, diabetes mellitus, renal failure, and complex coronary lesions. Essential thrombocythemia, a rare myeloproliferative disorder characterized by increased platelet count and megakaryocytic hyperplasia in the bone marrow, is rarely associated with ischemic cardiac events or coronary stent thrombosis. We describe a case of very late coronary drug-eluting stent thrombosis in a patient affected by essential thrombocythemia and with a platelet count of 780 000/mm3, presenting with acute myocardial infarction. In our opinion, this case report enriches the poor literature about the association between two so rare conditions; moreover, to our knowledge, this is the first case described in the literature of very late coronary stent thrombosis in a patient with this prothrombotic feature.

KW - Stent

KW - Thrombocytosis

KW - Thrombosis

UR - http://www.scopus.com/inward/record.url?scp=84864816125&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864816125&partnerID=8YFLogxK

U2 - 10.1714/1114.12248

DO - 10.1714/1114.12248

M3 - Articolo

VL - 13

SP - 520

EP - 522

JO - Giornale Italiano di Cardiologia

JF - Giornale Italiano di Cardiologia

SN - 1827-6806

IS - 7-8

ER -